GenoPalate, Inc.

GenoPalate, Inc. focuses on personalized nutrition by analyzing genetic data to offer tailored dietary recommendations that enhance metabolic health and improve overall eating habits. Founded in 2016, GenoPalate, Inc. operates from Milwaukee, US, providing personalized DNA nutrition plans.

The company has raised USD 3. 00 mn in Series B funding as of October 3, 2024, with a current valuation of USD 19. 798 mn. The founder's specific history is not detailed, but the company has made five notable deals since inception, maintaining a steady focus on the personalized nutrition market.

GenoPalate specializes in personalized DNA nutrition plans that utilize genetic analysis to provide tailored dietary recommendations. Their core offering includes the Essential Nutrition Report, generated through the analysis of over 150 genetic markers to inform users about their macro and micronutrient needs, food sensitivities, and optimal food choices. Customers can upload genetic data from services like 23andMe or AncestryDNA or use GenoPalate’s DNA Collection Kit. The company primarily serves consumers in the United States, with potential for international market reach.

GenoPalate generates revenue through the sale of personalized nutrition services, including the Essential Nutrition Report, priced at USD 99 during promotions and USD 149 for DNA testing via their Collection Kit. The transaction structure focuses on direct-to-consumer online sales, providing immediate access to customized reports, and may include subscription plans for ongoing dietitian coaching and support. In October 2024, GenoPalate, Inc. raised USD 3 million in Series B funding, which will support the development of new products and expansion into additional markets.

The company aims to enhance its offerings and grow its presence by targeting international markets while continuing to innovate in personalized nutrition solutions.